Aether Industries (AETHER) Q4 20/21 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 20/21 earnings summary
15 Oct, 2026Executive summary
FY21 operations continued through COVID-19 disruption; reported annual revenue was ₹454.22 Cr, up 50% YoY, with EBITDA of ₹113.97 Cr.
Net profit rose to ₹71.02 Cr from ₹39.61 Cr; EPS increased to ₹70.33 from ₹46.27.
Financial highlights
Income from operations was ₹450.23 Cr vs ₹301.87 Cr; total income was ₹454.12 Cr vs ₹303.85 Cr.
Profit before tax was ₹93.75 Cr vs ₹56.06 Cr; profit for the year was ₹71.02 Cr vs ₹39.61 Cr.
Finance costs rose to ₹9.74 Cr from ₹8.13 Cr; depreciation and amortization were ₹10.48 Cr vs ₹7.44 Cr.
Segment performance
Operations were concentrated in one Chemicals segment; no reportable geographical segment was identified.
Products and services served pharmaceutical, material science, agrochemical, electronic chemical, and fine and specialty chemical markets; business models included manufacturing, CRAMS, research, and technology development.
Latest events from Aether Industries
- Revenue and PAT rose sharply; EPS reached ₹24.89, with no dividend recommended.AETHER
Q4 18/19 - FY20 revenue grew 49.47%, net profit rose 70%, and the rating upgraded to ACUITE BBB.AETHERQ4 19/20
- Revenue and profit surged as capacity, R&D and CRAMS expansion accelerated.AETHERQ4 21/22
- FY23 growth and expansion advanced, but cash conversion and concentration risks persisted.AETHERQ4 22/23
- Q1 FY27 delivered 27% revenue growth, margin expansion, and major R&D and insurance milestones.AETHERQ1 26/27
- Q3 FY26 revenue up 44% YoY, EBITDA up 75%, with strong growth and capacity expansions.AETHERQ3 25/26
- Q3 FY25 delivered strong revenue and profit growth, supported by expansion and new contracts.AETHERQ3 24/25
- Q4 FY25 revenue up 90% Y/Y, PAT up 3621% Y/Y, with strong expansion and risk management.AETHERQ4 24/25
- Q1 FY26 revenue up 35% Y/Y, EBITDA up 94%, with major expansions and Milliken contract signed.AETHERQ1 25/26